Table 1 Patients baseline characteristics
|  | Total (n = 135) | MVO(-) (n = 49) | MVO( +) (n = 86) | p value |
|---|---|---|---|---|
Age, years | 60.72 ± 10.73 | 62.35 ± 8.44 | 59.79 ± 11.78 | 0.150 |
Female | 17 (12.70%) | 8 (16.30%) | 9 (10.50%) | 0.320 |
Body surface area, m2 | 1.82 ± 0.16 | 1.79 ± 0.16 | 1.84 ± 0.16 | 0.100 |
Body mass index, kg/m2 | 24.51 ± 2.86 | 23.86 ± 2.34 | 24.87 ± 3.07 | 0.050 |
Chest distress | 64 (47.40%) | 21 (42.90%) | 43 (50%) | 0.420 |
Chest pain | 126 (93.30%) | 45 (91.80%) | 81 (94.20%) | 0.870 |
Risk factors | ||||
 Hypertension | 71 (54.80%) | 23 (46.90%) | 51 (59.30%) | 0.170 |
 Diabetes mellitus (II) | 47 (34.80%) | 13 (26.50%) | 34 (39.50%) | 0.130 |
 Killip class |  |  |  | 0.710 |
  I | 118 (87.40%) | 44 (89.80%) | 74 (86%) |  |
  II | 11 (8.10%) | 4 (8.20%) | 7 (8.10%) |  |
  III–IV | 6 (4.40%) | 1 (2%) | 5 (5.80%) |  |
 CK-MBmax, U/L | 100.45 (61.70, 245.55) | 69 (39.70, 189.10) | 112.90 (80, 303) | 0.006 |
 cTnImax, ng/mL | 30 (14.38, 78.25) | 14.40 (6.57, 22.80) | 57 (25.50, 83) |  < 0.001 |
 BNPmax, pg/mL | 304 (135.75, 482.25) | 211 (100.50,459) | 350 (159.50, 496.50) | 0.020 |
 CRPmax, mg/L | 10.05 (4.67, 16.86) | 5.90 (2.15, 12.65) | 11.90 (7.70, 23.04) |  < 0.001 |
 MACE | 26 (19.26%) | 4 (8.20%) | 22 (25.60%) | 0.013 |
Angiographic | ||||
 Infarct-related artery |  |  |  | 0.360 |
  LAD | 101 (74.80%) | 35 (71.40%) | 66 (76.70%) |  |
  LCX | 6 (4.40%) | 1 (2%) | 5 (5.80%) |  |
  RCA | 28 (20.70%) | 13 (26.50%) | 15 (17.40%) |  |
 Segment of culprit vessel |  |  |  | 0.002 |
  Proximal | 74 (54.80%) | 19 (38.80%) | 56 (64%) |  |
  Middle | 49 (36.30%) | 21 (42.90%) | 28 (32.60%) |  |
  Distal | 12 (8.90%) | 9 (18.40%) | 3 (3.50%) |  |
 TIMI flow grade pre-PCI |  |  |  | 0.030 |
  0 | 89 (65.90%) | 24 (49%) | 65 (75.60%) |  |
  1 | 10 (7.40%) | 3 (6.10%) | 7 (8.10%) |  |
  2 | 11 (8.10%) | 7 (14.30%) | 4 (4.70%) |  |
  3 | 25 (18.50%) | 15 (30.60%) | 10 (11.60%) |  |
 TIMI flow grade post-PCI |  |  |  | 0.040 |
  1–2 | 26 (19.30%) | 5 (10.20%) | 21 (24.40%) |  |
  3 | 10,980.70%) | 44 (89.80%) | 68 (75.60%) |  |